894 related articles for article (PubMed ID: 18668431)
21. Role of the breast cancer resistance protein (ABCG2) in drug transport.
Mao Q; Unadkat JD
AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).
He SM; Li R; Kanwar JR; Zhou SF
Curr Med Chem; 2011; 18(3):439-81. PubMed ID: 21143116
[TBL] [Abstract][Full Text] [Related]
23. Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.
Ludwig JA; Szakács G; Martin SE; Chu BF; Cardarelli C; Sauna ZE; Caplen NJ; Fales HM; Ambudkar SV; Weinstein JN; Gottesman MM
Cancer Res; 2006 May; 66(9):4808-15. PubMed ID: 16651436
[TBL] [Abstract][Full Text] [Related]
24.
Jiang B; Yan LJ; Wu Q
DNA Cell Biol; 2019 May; 38(5):485-490. PubMed ID: 30977678
[TBL] [Abstract][Full Text] [Related]
25. The structure and functions of P-glycoprotein.
Li Y; Yuan H; Yang K; Xu W; Tang W; Li X
Curr Med Chem; 2010; 17(8):786-800. PubMed ID: 20088754
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
Zhu CY; Lv YP; Yan DF; Gao FL
Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
[TBL] [Abstract][Full Text] [Related]
27. A novel MDR1 GT1292-3TG (Cys431Leu) genetic variation and its effect on P-glycoprotein biologic functions.
Crouthamel MH; Wu D; Yang Z; Ho RJ
AAPS J; 2010 Dec; 12(4):548-55. PubMed ID: 20623213
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies.
Jamroziak K; Robak T
Hematology; 2004 Apr; 9(2):91-105. PubMed ID: 15203864
[TBL] [Abstract][Full Text] [Related]
29. Utility of Mdr1-gene deficient mice in assessing the impact of P-glycoprotein on pharmacokinetics and pharmacodynamics in drug discovery and development.
Chen C; Liu X; Smith BJ
Curr Drug Metab; 2003 Aug; 4(4):272-91. PubMed ID: 12871045
[TBL] [Abstract][Full Text] [Related]
30. A T3587G germ-line mutation of the MDR1 gene encodes a nonfunctional P-glycoprotein.
Mutoh K; Mitsuhashi J; Kimura Y; Tsukahara S; Ishikawa E; Sai K; Ozawa S; Sawada J; Ueda K; Katayama K; Sugimoto Y
Mol Cancer Ther; 2006 Apr; 5(4):877-84. PubMed ID: 16648557
[TBL] [Abstract][Full Text] [Related]
31. P-glycoprotein-mediated efflux as a major factor in the variance of absorption and distribution of drugs: modulation of chemotherapy resistance.
Johnson WW
Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):501-14. PubMed ID: 12500430
[TBL] [Abstract][Full Text] [Related]
32. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
Breier A; Barancík M; Sulová Z; Uhrík B
Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathways: regulation and therapeutic implications of multidrug resistance.
Chen KG; Sikic BI
Clin Cancer Res; 2012 Apr; 18(7):1863-9. PubMed ID: 22344233
[TBL] [Abstract][Full Text] [Related]
34. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
[TBL] [Abstract][Full Text] [Related]
35. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line.
Zrieki A; Farinotti R; Buyse M
Pharm Res; 2008 Sep; 25(9):1991-2001. PubMed ID: 18581209
[TBL] [Abstract][Full Text] [Related]
37. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
[No Abstract] [Full Text] [Related]
38. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.
Choudhuri S; Klaassen CD
Int J Toxicol; 2006; 25(4):231-59. PubMed ID: 16815813
[TBL] [Abstract][Full Text] [Related]
39. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
Shen XM; Cheng J
DNA Cell Biol; 2019 Mar; 38(3):250-255. PubMed ID: 30632789
[TBL] [Abstract][Full Text] [Related]
40. Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice.
Ozgür B; Saaby L; Janfelt C; Langthaler K; Eneberg E; Jacobsen AM; Badolo L; Montanari D; Brodin B
Eur J Pharm Biopharm; 2021 Dec; 169():211-219. PubMed ID: 34756975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]